{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=LEO+124249", "query": { "intervention": "LEO 124249" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 6, "total_pages": 1, "next_page_url": null, "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-11T17:33:13.035Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT02561585", "title": "LEO 124249 Ointment in the Treatment of Alopecia Areata", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Alopecia Areata" ], "interventions": [ { "name": "LEO 124249", "type": "DRUG" }, { "name": "Vehicle", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "LEO Pharma", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 40, "start_date": "2016-01", "completion_date": "2016-12", "has_results": true, "last_update_posted_date": "2025-03-06", "last_synced_at": "2026-09-11T17:33:13.035Z", "location_count": 2, "location_summary": "Evanston, Illinois • New York, New York", "locations": [ { "city": "Evanston", "state": "Illinois" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT02561585" }, { "nct_id": "NCT05332366", "title": "A Trial to Assess the Effect of Delgocitinib Cream 20 mg/g on the Molecular Signature, Safety, and Efficacy in Adults With Frontal Fibrosing Alopecia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Frontal Fibrosing Alopecia" ], "interventions": [ { "name": "Delgocitinib cream", "type": "DRUG" }, { "name": "Delgocitinib cream vehicle", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "LEO Pharma", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 35, "start_date": "2022-04-19", "completion_date": "2023-05-22", "has_results": true, "last_update_posted_date": "2025-03-06", "last_synced_at": "2026-09-11T17:33:13.035Z", "location_count": 1, "location_summary": "Burlington, Massachusetts", "locations": [ { "city": "Burlington", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT05332366" }, { "nct_id": "NCT03683719", "title": "Phase 2b Dose-ranging Trial to Evaluate Delgocitinib Cream 1, 3, 8, and 20 mg/g Compared to Delgocitinib Cream Vehicle Over a 16-week Treatment Period in Adult Subjects With Chronic Hand Eczema", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Chronic Hand Eczema" ], "interventions": [ { "name": "Delgocitinib cream", "type": "DRUG" }, { "name": "Delgocitinib cream vehicle", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "LEO Pharma", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 258, "start_date": "2018-11-28", "completion_date": "2020-04-20", "has_results": true, "last_update_posted_date": "2025-03-12", "last_synced_at": "2026-09-11T17:33:13.035Z", "location_count": 4, "location_summary": "Tucson, Arizona • Hialeah, Florida • Portland, Oregon", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Hialeah", "state": "Florida" }, { "city": "Portland", "state": "Oregon" }, { "city": "Portland", "state": "Oregon" } ], "official_url": "https://clinicaltrials.gov/study/NCT03683719" }, { "nct_id": "NCT03725722", "title": "Dose-ranging Trial to Evaluate Delgocitinib Cream 1, 3, 8, and 20 mg/g Compared to Delgocitinib Cream Vehicle Over an 8-week Treatment Period in Adult Subjects With Atopic Dermatitis.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Atopic Dermatitis" ], "interventions": [ { "name": "Delgocitinib cream", "type": "DRUG" }, { "name": "Delgocitinib cream vehicle", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "LEO Pharma", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 251, "start_date": "2018-12-28", "completion_date": "2020-05-19", "has_results": true, "last_update_posted_date": "2025-03-12", "last_synced_at": "2026-09-11T17:33:13.035Z", "location_count": 11, "location_summary": "Birmingham, Alabama • Encino, California • Los Angeles, California + 7 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Encino", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Rolling Hills Estates", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03725722" }, { "nct_id": "NCT03958955", "title": "Efficacy and Safety of Delgocitinib Cream in Discoid Lupus Erythematosus.", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Discoid Lupus Erythematosus" ], "interventions": [ { "name": "Delgocitinib cream", "type": "DRUG" }, { "name": "Delgocitinib cream vehicle", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "LEO Pharma", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 27, "start_date": "2019-07-09", "completion_date": "2020-04-30", "has_results": true, "last_update_posted_date": "2025-03-06", "last_synced_at": "2026-09-11T17:33:13.035Z", "location_count": 5, "location_summary": "San Diego, California • Skokie, Illinois • Boston, Massachusetts + 2 more", "locations": [ { "city": "San Diego", "state": "California" }, { "city": "Skokie", "state": "Illinois" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Forest Hills", "state": "New York" }, { "city": "Cincinnati", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT03958955" }, { "nct_id": "NCT03826901", "title": "Delgocitinib Cream for the Treatment of Moderate to Severe Atopic Dermatitis During 8 Weeks in Adults, Adolescents, and Children", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Atopic Dermatitis" ], "interventions": [ { "name": "delgocitinib", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "LEO Pharma", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "2 Years", "maximum_age": null, "sex": "ALL", "summary": "2 Years and older" }, "enrollment_count": 46, "start_date": "2019-02-20", "completion_date": "2021-10-29", "has_results": false, "last_update_posted_date": "2025-02-24", "last_synced_at": "2026-09-11T17:33:13.035Z", "location_count": 12, "location_summary": "Birmingham, Alabama • Phoenix, Arizona • Fountain Valley, California + 9 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Fountain Valley", "state": "California" }, { "city": "Irvine", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03826901" } ] }